The drug, called CagriSema, was generally safe, with nausea, vomiting, diarrhea and constipation among the most common side effects similar to those seen with other GLP-1 treatments already on the market
Quick wellness shots, including B12, NAD+, Super Lipo, and anti-nausea injections
GI effects are usually minimal at this dose
One of the defining features of gastroparesis is delayed gastric emptying, accompanied by gastrointestinal symptoms like early fullness after meals, abdominal pain, nausea, vomiting, belching, and bloating, the motion states
Symptoms include: Difficulty breathing or swallowing Severe rash or itching Swelling of your face, lips, tongue, or throat If you experience these serious side effects, talk with your medical provider right away
CJC-1295 No DAC, also referred to as Modified GRF 1-29, is a modified analogue of growth hormone-releasing hormone used in research models examining short-acting GHRH receptor pathway activity